A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

United States

Investigative Site, Chicago, Illinois

Investigative Site, Bethesda, Maryland

Investigative Site, Boston, Massachusetts

Investigative Site, Rochester, Minnesota

Investigative Site, New York, New York

Investigative Site, Canton, Ohio

Investigative Site, Portland, Oregon

Investigative Site, Houston, Texas

France

Investigative Site, Clichy, Île-de-France Region

Netherlands

Investigative Site, Rotterdam, South Holland

Switzerland

Investigative Site, Basel, Canton Basel-Stadt

United Kingdom

Investigative Site, Saint Johns Wood, London

Investigative Site, Withington, Manchester